PA8500101A1 - COMPOSITIONS AND METHODS TO TREAT ALLERGIC AND INFLAMMATORY CONDITIONS WITH YOU - Google Patents

COMPOSITIONS AND METHODS TO TREAT ALLERGIC AND INFLAMMATORY CONDITIONS WITH YOU

Info

Publication number
PA8500101A1
PA8500101A1 PA20008500101A PA8500101A PA8500101A1 PA 8500101 A1 PA8500101 A1 PA 8500101A1 PA 20008500101 A PA20008500101 A PA 20008500101A PA 8500101 A PA8500101 A PA 8500101A PA 8500101 A1 PA8500101 A1 PA 8500101A1
Authority
PA
Panama
Prior art keywords
inflammatory conditions
methods
compositions
antihistamine
treat
Prior art date
Application number
PA20008500101A
Other languages
Spanish (es)
Inventor
Lugo Sergio Rolando Ulloa
Ramos Jose De Jesus Villacampa
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PA8500101A1 publication Critical patent/PA8500101A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBEN MÉTODOS PARA TRATAR Y/O PREVENIR CONDICIONES ALÉRGICAS E INFLAMATORIAS CON TOS EN HUMANOS QUE REQUIERAN DICHO TRATAMIENTO Y/O PREVENCIÓN, LOS CUALES COMPRENDEN ADMINISTRAR UNA CANTIDAD EFECTIVA DE UNA ANTIHISTAMINA NO SEDANTE EN COMBINACIÓN CON UN EXPECTORANTE; LAS MODALIDADES QUE SE PREFIEREN INCLUYEN AQUELLAS EN LAS QUE LA ANTIHISTAMINA NO SEDANTE ES LORATADINA Y EL EXPECTORANTE ES AMBROXOL; SE PROVEEN TAMBIÉN COMPOSICIONES FARMACÉUTICAS NOVEDOSAS PARA TRATAR Y/O PREVENIR CONDICIONES ALÉRGICAS E INFLAMATORIAS CON TOS EN HUMANOS, LAS CUALES COMPRENDEN UNA CANTIDAD EFECTIVA DE UNA ANTIHISTAMINA NO SEDANTE EN COMBINACIÒN CON UN EXPECTORANTE Y UN VEHÍCULO FARMACÉUTICAMENTE ACEPTABLE.METHODS ARE DESCRIBED TO TREAT AND / OR PREVENT ALLERGIC AND INFLAMMATORY CONDITIONS WITH THOSE IN HUMANS THAT REQUIRE SUCH TREATMENT AND / OR PREVENTION, WHICH INCLUDE TO ADMINISTER AN EFFECTIVE AMOUNT OF AN ANTIHISTAMINE IN A COMBINING CONDITION; THE MODES THAT ARE PREFERRED INCLUDE THOSE IN WHICH THE NON-SISTING ANTIHISTAMINE IS LORATADINE AND THE EXPECTORANT IS AMBROXOL; ALSO NOVEDOUS PHARMACEUTICAL COMPOSITIONS ARE PROVIDED TO TREAT AND / OR PREVENT ALLERGIC AND INFLAMMATORY CONDITIONS WITH THOSE IN HUMANS, WHICH UNDERSTAND AN EFFECTIVE AMOUNT OF AN ANTIHISTAMINE NOT IN COMBINANT AND AN EXPECTABLE VEHICLE.

PA20008500101A 2000-03-30 2000-08-17 COMPOSITIONS AND METHODS TO TREAT ALLERGIC AND INFLAMMATORY CONDITIONS WITH YOU PA8500101A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19331000P 2000-03-30 2000-03-30

Publications (1)

Publication Number Publication Date
PA8500101A1 true PA8500101A1 (en) 2002-09-17

Family

ID=22713096

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20008500101A PA8500101A1 (en) 2000-03-30 2000-08-17 COMPOSITIONS AND METHODS TO TREAT ALLERGIC AND INFLAMMATORY CONDITIONS WITH YOU

Country Status (13)

Country Link
CN (1) CN1422162A (en)
AR (1) AR025308A1 (en)
AU (2) AU2001247867B2 (en)
BR (1) BR0003648A (en)
CO (1) CO5200779A1 (en)
CR (1) CR6232A (en)
NZ (1) NZ520826A (en)
PA (1) PA8500101A1 (en)
PE (1) PE20010576A1 (en)
SG (1) SG96611A1 (en)
TW (1) TWI243671B (en)
WO (1) WO2001074341A2 (en)
ZA (1) ZA200102605B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005123052A1 (en) * 2004-06-18 2005-12-29 Jiangsu Hengrui Medicine Co., Ltd. Drug composition containing ambroxol and erdosteine or acetylcysteine
CN1323662C (en) * 2004-06-18 2007-07-04 江苏恒瑞医药股份有限公司 Pharmaceutical composition containing ambroxol and erdosteine or acetylcysteine and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
BR9407414A (en) * 1993-09-07 1996-11-12 Procter & Gamble Compositions containing a non-steroidal propionic acid anti-inflammatory agent amino acid salt and at least one decongestant an expectorant an antihistamine and an antitussive
US6160020A (en) * 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen

Also Published As

Publication number Publication date
AR025308A1 (en) 2002-11-20
TWI243671B (en) 2005-11-21
WO2001074341A2 (en) 2001-10-11
BR0003648A (en) 2002-01-02
AU4786701A (en) 2001-10-15
CR6232A (en) 2008-12-01
CN1422162A (en) 2003-06-04
ZA200102605B (en) 2001-10-03
WO2001074341A3 (en) 2002-05-16
PE20010576A1 (en) 2001-05-08
AU2001247867B2 (en) 2005-09-01
NZ520826A (en) 2004-07-30
CO5200779A1 (en) 2002-09-27
SG96611A1 (en) 2003-06-16

Similar Documents

Publication Publication Date Title
AR028296A1 (en) SYNERGISTIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
DE60216122D1 (en) CYSTONE PROTEASE INHIBITOR WITH 2-CYANO-4-AMINO-PYRIMIDINE STRUCTURE AND CATHEPSINE K-HEMDERING EFFECT FOR THE TREATMENT OF INFLAMMATORY DISEASE AND OTHER DISORDERS
ATE514418T1 (en) RAPIDLY DISRUPTING SOLID DOSAGE FORMS WITH NON-FRUABLE CONSISTENCY AND PULLULAN
CR6210A (en) CELECOXIB COMPOSITIONS
UY27465A1 (en) METHODS AND COMPOSITIONS TO TREAT FLAVIVIRUS AND PESTIVIRUS WITH 4 'NUCLEOSID MODIFICATIONS
UY28041A1 (en) LOW DOSE METHODS FOR THE TREATMENT OF DISORDERS IN WHICH TNFA'S ACTIVITY IS HARMFUL.
DK1071417T3 (en) Use of cannabidiol as an anti-inflammatory agent
ECSP056229A (en) A PHARMACEUTICAL COMPOSITION THAT INCLUDES POLYMODIC FORMS OF 3- (4-AMINO-1-OXO-1.3 DYHIDRO-ISOINDOL-2-IL) -PIPERIDINA-2,6-DIONA FOR THE TREATMENT AND HANDLING OF CANCERES
PA8657201A1 (en) COMPOUNDS OF 3H-OXAZOLO AND 3H-TIAZOLO [4, 5-D] PIRIMIDIN-2-ONA 3, 5-DISUSTITUED AND 3, 5, 7 - TRISUSTITUIDA AND PROFARMACOS OF THE SAME
CY1110133T1 (en) HYPERPLOYEES THERAPEUTIC THERAPY INCLUDING PITAVASTATINES AND VISCENTAGENIC ACID
AR028512A1 (en) ANTIMICROBIAL COMPOSITIONS ACIDED FOR THE TREATMENT OF FOODS AND SURFACES THAT CONTACT FOODS AND METHODS FOR THE USE OF THESE
NO20060424L (en) 5-heteroration-based P38 kinase inhibitors
DE60235083D1 (en) SUBSTITUTED TETRACYCLIN COMPOUNDS FOR THE TREATMENT OF MALARIA
EE05417B1 (en) Combination therapy of epothilone analogues with chemotherapeutic agents
AR109263A2 (en) COMPOSITION INCLUDING MOXIDECTINE
ATE512163T1 (en) ADMINISTRATION OF AGENTS FOR THE TREATMENT OF INFLAMMATION
EA200300953A1 (en) THERAPEUTIC COMBINATIONS FOR USE IN CARDIOVASCULAR AND INFLAMMATORY DISEASES
PA8502901A1 (en) TREATMENT OF COMBINATION WITH IL-1RA AND COMPOUNDS THAT INHIBIT THE PROCESSING AND RELEASE OF IL-1
CY1108932T1 (en) Compounds 4- (heterocyclyl) -benzenesulfoximine for the therapeutic treatment of inflammatory diseases
NO20070580L (en) Treatment of cancer.
BR0313611A (en) Use of the ciclesonide and antihistamine combination for the treatment of allergic rhinitis
AR021155A1 (en) TREATMENT OF NEUROTIC DISORDERS
AR028502A1 (en) TREATMENT OF ALLERGIC INFLAMMATORY CONDITIONS
HUP0200152A2 (en) Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites
PA8525801A1 (en) PIRAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS TO MODULATE AND / OR INHIBIT THE ACTIVITY OF ERAB / HADH2